NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Clinical trials for NEUROMYELITIS OPTICA SPECTRUM DISORDERS explained in plain language.
Never miss a new study
Get alerted when new NEUROMYELITIS OPTICA SPECTRUM DISORDERS trials appear
Sign up with your email to follow new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on multiple sclerosis and myasthenia gravis
Disease control Not yet recruitingThis early-phase study tests a new treatment called QT-019C, which uses specially engineered immune cells (CAR T-cells) to target and attack faulty immune cells in people with severe autoimmune diseases like multiple sclerosis, neuromyelitis optica, and myasthenia gravis. Up to 1…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Phase: EARLY_PHASE1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Silent attacks in NMOSD: new study aims to spot trouble before it starts
Knowledge-focused Not yet recruitingThis study watches 50 people with neuromyelitis optica spectrum disorder (NMOSD) who seem stable on rituximab. Researchers use blood tests and MRI scans to find hidden signs of nerve damage that might predict future relapses or disability. The goal is to better understand the dis…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 26, 2026 10:42 UTC